Top

Aequus Pharmaceuticals Inc.

TSXV Exchange | Aug 4, 2020, 10:12 AM EDT | Real-time price

AQS $ 0.11 RT
CHANGE
0.01 (10.00%)
VOLUME
285,002
Day Low: 0.10
Day High: 0.11
Detailed Quote
Open: 0.10
High: 0.11
Beta: 0.3532
Shares Out.: 60,050,845
Total Shares (All Classes)2: 80,437,970
Prev. Close: 0.10
Low: 0.10
VWAP: 0.1078
Escrow Shares: 20,387,125
Market Cap (All Classes)2*: 8,848,177
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 80,437,970
EPS: -0.04
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -5.50
Market Cap1: 8,848,177
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others. More

News Headlines for Aequus Pharmaceuticals Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links

Note: as part of an update to TMX Money, this link will be removed on June 30, 2020. Users wishing to access InfoTSXV can continue to do so directly

News Headlines for Aequus Pharmaceuticals Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.